Article info
Editorial commentary
Necrotising autoimmune myopathy (NAM): antibodies seem to be specific markers in aiding diagnosis
- Correspondence to Professor Marinos C Dalakas, Department of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USA; mdalakas{at}med.uoa.gr
Citation
Necrotising autoimmune myopathy (NAM): antibodies seem to be specific markers in aiding diagnosis
Publication history
- Received March 30, 2016
- Accepted April 3, 2016
- First published May 5, 2016.
Online issue publication
September 20, 2016
Article Versions
- Previous version (13 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/